Skip to main content
. 2021 Nov 24;14:54. doi: 10.1186/s13039-021-00575-w

Table 3.

Patient characteristics

Patient ID a Ageb/sex SBDS mutations
1 6/M c.183_184delTAinsCT/c.258 + 2 T > C
2 4/M c.258 + 2 T > C/c.258 + 2 T > C
3 20/F c.183_184delTAinsCT/c.258 + 2 T > C
4 5/M c.183_184delTAinsCT/c.258 + 2 T > C
5 11/M c.170 T > C/258 + 2 T > C
6 14/M c.258 + 2 T > C/c.258 + 2 T > C
7 29/M c.183_184delTAinsCT/c.258 + 2 T > C
8 16/M c.183_184delTAinsCT/c.258 + 2 T > C
9 11, 19/M c.183_184delTAinsCT + 258 + 2 T > C/258 + 2 T > C
10 13, 16/F c.183_184delTAinsCT/c.258 + 2 T > C
11 15/F c.183_184delTAinsCT/c.258 + 2 T > C
12 M c.183_184delTAinsCT/c.258 + 2 T > C
13 13, 14/M c.183_184delTAinsCT + 258 + 2 T > C/c.258 + 2 T > C
14 3, 5/M c.183_184delTAinsCT + 258 + 2 T > C/c.258 + 2 T > C

aPatients 1–8 from the cohort of the North American Shwachman-Diamond Syndrome Registry (SDSR); patients 9–14 from the cohort of the Registro Italiano per la Sindrome di Shwachman-Diamond (RI-SDS)

bAge (years) at time or times of BM sampling